Funds and ETFs Pharmaron Beijing Co., Ltd.
Equities
300759
CNE100003JW4
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
19.95 CNY | +4.12% | +9.80% | -31.16% |
Apr. 29 | Nomura Adjusts Pharmaron’s Price Target to 31.41 Yuan From 36.68 Yuan, Keeps at Buy | MT |
Apr. 26 | Pharmaron Beijing Posts 34% Profit Drop in Q1 as Revenue Slips 2% | MT |
ETFs positioned on Pharmaron Beijing Co., Ltd.
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.17% | 2 M€ | -14.86% | - | |
0.13% | 35 M€ | -5.85% | - | |
0.10% | 3 M€ | +0.62% | - | |
0.06% | 2 M€ | -.--% | ||
0.05% | 4 M€ | -11.56% | ||
0.03% | 7 M€ | -.--% | - | |
0.01% | 117 M€ | +1.54% | - | |
0.01% | 2,808 M€ | +6.68% | - | |
0.01% | 441 M€ | +5.00% | - | |
0.01% | 149 M€ | +3.21% | - | |
0.00% | 4 M€ | -4.41% | - | |
0.00% | 7 M€ | +2.68% | - | |
0.00% | 34 M€ | +2.43% | - | |
0.00% | 147 M€ | +4.88% | - | |
0.00% | 15 M€ | +13.01% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-31.16% | 4.29B | |
+1.77% | 42.75B | |
+47.70% | 41.61B | |
+12.24% | 41.34B | |
-8.83% | 26.59B | |
+7.44% | 25.49B | |
-23.01% | 18.12B | |
+30.56% | 12.24B | |
-1.82% | 11.76B | |
+8.35% | 11B |
- Stock Market
- Equities
- 300759 Stock
- Funds and ETFs Pharmaron Beijing Co., Ltd.